The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[[7-acetyl-3-(2-furylmethyl)-4-oxo-6,8-dihydro-5H-pyrido[2,3]thieno[2,4-b]pyrimidin-2-yl]sulfanyl]-N-(4-acetylphenyl)acetamide ID: ALA5086321
Cas Number: 1189944-52-2
PubChem CID: 50799637
Max Phase: Preclinical
Molecular Formula: C26H24N4O5S2
Molecular Weight: 536.64
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)c1ccc(NC(=O)CSc2nc3sc4c(c3c(=O)n2Cc2ccco2)CCN(C(C)=O)C4)cc1
Standard InChI: InChI=1S/C26H24N4O5S2/c1-15(31)17-5-7-18(8-6-17)27-22(33)14-36-26-28-24-23(25(34)30(26)12-19-4-3-11-35-19)20-9-10-29(16(2)32)13-21(20)37-24/h3-8,11H,9-10,12-14H2,1-2H3,(H,27,33)
Standard InChI Key: HNQWNNUKTSPZBM-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
-2.0982 0.4310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3837 0.8435 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6692 0.4310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3837 -0.8065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0982 -0.3940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8828 0.6859 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.8828 -0.6489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3678 0.0185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2185 -1.4026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0391 -1.4887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5240 -0.8213 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.1883 -0.0675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3493 -0.8213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7620 -1.5360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7620 -0.1065 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3837 -1.6318 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0454 0.8436 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.7601 0.4310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4749 0.8436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1897 0.4310 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4749 1.6690 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0454 -0.8066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0454 -1.6355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7128 -2.1203 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.4579 -2.9049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3669 -2.9049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6218 -2.1203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6692 -0.3940 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9043 0.8436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9046 1.6690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6176 2.0797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3325 1.6669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3341 0.8457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6222 0.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0472 2.0796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0472 2.9049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7620 1.6669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 2 2 0
1 5 2 0
5 4 1 0
1 6 1 0
5 7 1 0
7 8 2 0
8 6 1 0
7 9 1 0
10 9 1 0
11 10 1 0
12 11 1 0
8 12 1 0
11 13 1 0
13 14 1 0
13 15 2 0
4 16 2 0
3 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
19 21 2 0
22 23 1 0
24 23 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 23 2 0
28 22 1 0
4 28 1 0
3 28 1 0
20 29 1 0
30 29 2 0
31 30 1 0
32 31 2 0
33 32 1 0
34 33 2 0
29 34 1 0
32 35 1 0
35 36 2 0
35 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 536.64Molecular Weight (Monoisotopic): 536.1188AlogP: 3.94#Rotatable Bonds: 7Polar Surface Area: 114.51Molecular Species: NEUTRALHBA: 9HBD: 1#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.17CX Basic pKa: 2.07CX LogP: 2.60CX LogD: 2.60Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.22Np Likeness Score: -2.52
References 1. Carrasco K, Montersino C, Derviaux C, Saez-Ayala M, Hoffer L, Restouin A, Castellano R, Casassa J, Roche P, Pasquier E, Combes S, Morelli X, Collette Y, Betzi S.. (2022) CRCM5484: A BET-BDII Selective Compound with Differential Anti-leukemic Drug Modulation., 65 (7.0): [PMID:35348328 ] [10.1021/acs.jmedchem.1c02168 ]